Correlation between Anthropometric Measures, Lipid Profile and Serum Adiponectin and Steatosis in Nondiabetic Nonalcoholic Fatty Liver Disease

References (33)

1. 1 Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge [DOI]
2. 2 Steatohepatitis: A tale of two “hits”? [DOI]
3. 3 Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions [DOI]
4. 4 Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆ [DOI]
5. 5 Nonalcoholic Steatohepatitis [DOI]
6. 6 Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma [DOI]
7. 7 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [DOI]
8. 8 AGA technical review on nonalcoholic fatty liver disease [DOI]
9. 9 Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease [DOI]
10. 10 Non-alcoholic fatty liver disease: The mist gradually clears [DOI]
11. 11 Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study [DOI]
12. 12 Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance [DOI]
13. 13 Fatty Infiltration of Liver in Hyperlipidemic Patients [DOI]
14. 14 Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive [DOI]
15. 15 Non-Alcoholic Fatty Liver Disease in Older People [DOI]
16. 16 The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease [DOI]
17. 17 Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease [DOI]
18. 18 Abdominal Obesity and Fatty Liver [DOI]
19. 19 Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment [DOI]
20. 20 Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity [DOI]
21. 21 Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications [DOI]
22. 22 The serum profile of adipokines in overweight patients with metabolic syndrome.
23. 23 The Fluctuation of Serum Levels of Aminotransferase in Patients With Nonalcoholic Steatohepatitis [DOI]
24. 24 Subacute liver failure in obese women [DOI]
25. 25 Insulin resistance and metabolic syndrome in chronic liver diseases: Old entities with new implications [DOI]
26. 26 Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF) [DOI]
27. 27 Frequency of non-alcoholic fatty liver disease in overweight/obese children and adults: Clinical, sonographic picture and biochemical assessment [DOI]
28. 28 Liver ultrasound is more sensitive in assessing the severity of nonalcoholic fatty liver disease with homeostasis model assessment-insulin resistance [DOI]
29. 29 Leptin in nonalcoholic steatohepatitis: is it one of the “hits”? [DOI]
30. 30 Role of Serum Adiponectin, IL-6 and Hs CRP in Nonalcoholic Fatty Liver Egyptian Patients [DOI]
31. 31 [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
32. 32 Abdominal Ultrasound for Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) [DOI]
33. 33 Molecular basis of insulin action [DOI]

Cited by 13

Showing 9 of 13 known citations — external sources report more than can currently be individually listed.

Related research

• Comparing Diagnostic Accuracy of USG and CT Scan in Detecting Fatty Liver in Indonesian Patients: Implications for Screening and Management — shares topic coverage
• Role of Serum Adiponectin, IL-6 and Hs CRP in Nonalcoholic Fatty Liver Egyptian Patients — shares topic coverage
• Diet Therapies for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Style Review — shares topic coverage
• Effect of Progressive Resistance Exercise Training on Hepatic Fat in Asian Indians with Non-Alcoholic Fatty Liver Disease — shares topic coverage
• Metabolic Inflammation in Obesity and NAFLD: Pathological Basis and Emerging Pharmacologic Interventions — shares topic coverage